Breaking News

Akorn Acquires Assets from Kilitch, NBZ

Gains five cGMP manufacturing sites, including CMO operations

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Akorn, Inc. has entered into an agreement to acquire certain assets of Kilitch Drugs Ltd. (KDIL), a contract manufacturer of sterile injectables in India, and certain assets of NBZ Pharma Ltd., for approximately $52 million in cash plus future milestones payments totaling as much as $6 million. The assets include KDIL’s plant in Paonta Sahib in Himachal Pradesh, India, along with the associated contract manufacturing and international business, and certain product transfers from KDIL’s Navi Mumb...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters